BioGend Therapeutics Co., Ltd. (6733)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
25. 70
-0.25
-0.9634%
NT$
4.5B Market Cap
- P/E Ratio
- Div Yield
57,419 Volume
- Eps
NT$ 25.95
Previous Close Want to track 6733 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
6733 Earnings Reports FAQ
What is the earnings per share (EPS) for 6733?
EPS data for 6733 is currently not available, as BioGend Therapeutics Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
BioGend Therapeutics Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
BioGend Therapeutics Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for BioGend Therapeutics Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 6733 at this time, as BioGend Therapeutics Co., Ltd has no recent EPS data to calculate it.
